NLRP3 and in situ carcinoma: In line with this, our results demonstrated increased levels of the inflammasome NLRP3 and the oxidative marker 4-HNE, accompanied by the decreased expression of HO-1 and SOD-1 in the DRG of CIS-injected male and female mice.